FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Sumatriptan Succinate Tablets Recall

Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Jan 22, 2020
Recall ID
D-0659-2020
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Sumatriptan Succinate Tablets starting Dec 26, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0659-2020 on Jan 22, 2020. Reason: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Product description

Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

Lot numbers, UPCs & expiration codes

a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020

Where it was sold

Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0659-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 26, 2019
FDA report date
Jan 22, 2020
Quantity
384/100 count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0659-2020, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
84570
Address
270 Prospect Plains Rd
Code information
a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020
Postal code
08512-3605
Report date
Jan 22, 2020
Product type
Drugs
Recall number
D-0659-2020
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
384/100 count bottles
Termination date
Oct 22, 2020
Reason for recall
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ
Distribution pattern
Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
Recall initiation date
Dec 26, 2019
Initial firm notification
Letter
Center classification date
Jan 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0659-2020, published Jan 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls